Review of Multimodality Management of Anaplastic Thyroid Cancer

To describe the outcome of patients with anaplastic thyroid cancer treated with hyperfractionated radiotherapy and concomitant chemotherapy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anaplastic Thyroid Cancer Carcinoma Neoplasms Neoplasms by Histologic Type Neoplasms, Glandular and Epithelial Thyroid Carcinoma, Anaplastic

Sex eligibility

All sexes

Study type

Observational

Primary location

Tom Baker Cancer Centre

Calgary, Alberta, T2N 4N2, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

anaplastic thyroid cancer treated with multimodality treatment

Exclusion criteria

differentiated thyroid cancer

Sponsors and collaborators

Lead sponsor

Alberta Health services

Other

Registry information

Official study title

A Retrospective Review of Multimodality Management of Anaplastic Thyroid Cancer

Important dates

Study start: 2006
Primary completion: 2006
Study completion: 2006
First posted: Jan 24, 2006
Registry last updated: Nov 21, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed